Results 11 to 20 of about 532,362 (323)

Luteal Phase Support in IVF: Comparison Between Evidence-Based Medicine and Real-Life Practices

Frontiers in Endocrinology, 2020
Background: Luteal phase support (LPS) in assisted reproduction cycles has been widely investigated in recent years. Although progesterone represents the preferential product for luteal phase supplementation in cycles with fresh embryo transfer, there is
Federica Di Guardo, Federica Di Guardo, Habib Midassi, Annalisa Racca, Herman Tournaye, Michel De Vos, Christophe Blockeel   +6 more
doaj   +2 more sources

A 10-year follow‐up on the practice of luteal phase support using worldwide web‐based surveys

Reproductive Biology and Endocrinology, 2021
Background It has been demonstrated that luteal phase support (LPS) is crucial in filling the gap between the disappearance of exogenously administered hCG for ovulation triggering and the initiation of secretion of endogenous hCG from the implanting ...
Gon Shoham, Milton Leong, Ariel Weissman
doaj   +2 more sources

Do early luteal serum progesterone levels predict the reproductive outcomes in IVF with oral dydrogesterone for luteal phase support?

PLoS ONE, 2019
ObjectiveWe sought to determine whether the early luteal serum progesterone (P4) level predicts the success of IVF treatment with oral dydrogesterone for luteal support.MethodThis retrospective monocentric cohort study included 242 women who underwent ...
Antoine Netter, Julien Mancini, Christophe Buffat, Aubert Agostini, Jeanne Perrin, Blandine Courbiere   +5 more
doaj   +2 more sources

Gonadotropin-releasing hormone agonist for ovulation trigger – OHSS prevention and use of modified luteal phase support for fresh embryo transfer

Upsala Journal of Medical Sciences, 2020
The introduction of gonadotrophin-releasing hormone agonist (GnRHa) trigger greatly impacted modern IVF treatment. Patients at low risk of ovarian hyperstimulation syndrome (OHSS) development, undergoing fresh embryo transfer and GnRHa trigger can be ...
Juan Carlos Castillo, Thor Haahr, María Martínez-Moya, Peter Humaidan   +3 more
doaj   +2 more sources

Luteal Phase Support in In Vitro Fertilization [PDF]

Seminars in Reproductive Medicine, 2015
It has been well demonstrated that luteal phase physiology is disrupted in in vitro fertilization (IVF) cycles conducted with either gonadotropin-releasing hormone (GnRH) agonists or antagonists, and that supplementation of the luteal phase with either exogenous progesterone or human chorionic gonadotropin (hCG) is necessary to optimize IVF cycle ...
exaly   +3 more sources

GnRH agonist as a luteal support in IVF cycle: mini-review—is there a role?

Middle East Fertility Society Journal, 2022
Background It has been established that assisted reproductive technology (ART) cycles are usually accompanied by a defective luteal phase, and that luteal phase support (LPS) is mandatory to improve reproductive outcomes.
Hasan Maghraby, Amr S. Abdelbadie, Ashraf Aboali, Aboubakr Elnashar   +3 more
doaj   +1 more source

Individualized luteal phase support using additional oral dydrogesterone in artificially prepared frozen embryo transfer cycles: is it beneficial?

Reproductive Biomedicine Online, 2023
RESEARCH QUESTION Does additional supplementation with oral dydrogesterone improve reproductive outcomes in patients with low serum progesterone concentrations on the day of frozen embryo transfer (FET) after artificial (HRT) endometrial preparation ...
S. Mackens, F. Pais, P. Drakopoulos, S. Amghizar, C. Roelens, L. Van Landuyt, H. Tournaye, M. De Vos, C. Blockeel   +8 more
semanticscholar   +1 more source

The inadequate corpus luteum

Reproduction and Fertility, 2021
The corpus luteum is the source of progesterone in the luteal phase of the cycle and the initial two-thirds of the first trimester of pregnancy. Normal luteal function is required for fertility and the maintenance of pregnancy.
W Colin Duncan
doaj   +1 more source

Individualized luteal phase support normalizes live birth rate in women with low progesterone levels on the day of embryo transfer in artificial endometrial preparation cycles.

Fertility and Sterility, 2021
OBJECTIVE To analyze the impact on live birth rates (LBRs) of the individualized luteal phase support (termed iLPS) in patients with low serum progesterone (P) levels compared with patients without iLPS.
E. Labarta, G. Mariani, C. Rodríguez-Varela, E. Bosch   +3 more
semanticscholar   +1 more source

Comparison of two micronized progesterones (Lutogel and Eutrogenic) in support of the luteal phase in patients undergoing IVF [PDF]

Majallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2021
Introduction: Luteal phase support is an inevitable part of IVF programs, for this purpose, progestogenic therapies are used. Lutogel and Utrogestan are two progestogenic therapies that can be used as supportive drugs for the luteal phase.
Sedigheh Hosseini, Saghar Salehpour, Leila Nazari, Nasrin Saharkhiz, Mona Esmi   +4 more
doaj   +1 more source